Dermata Therapeutics, Inc. (DRMA)

CIK 1853816 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dermata Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 2, 2026SCHEDULE 13G0000921895-26-002901
Oct 29, 20268-K0001493152-26-049312
Oct 21, 2026424B30001493152-26-047911
Oct 20, 2026EFFECT9999999995-26-003304
Oct 9, 2026S-30001493152-26-046518
Aug 18, 202640001493152-26-039048
Aug 18, 202640001493152-26-039046
Aug 17, 202625-NSE0001354457-26-000799
Aug 17, 20268-K0001493152-26-038647
Aug 11, 202610-Q0001493152-26-037127
Aug 11, 20268-K0001493152-26-037124
Aug 5, 20268-K0001493152-26-036109
Jun 16, 202640001493152-26-028884
Jun 4, 2026S-80001493152-26-027275
Jun 1, 2026SCHEDULE 13D0001493152-26-026642
May 29, 2026EFFECT9999999995-26-001810
May 29, 2026424B30001493152-26-026446
May 27, 20268-K0001493152-26-025441
May 22, 2026S-3/A0001493152-26-025073
May 13, 20268-K0001493152-26-022710
May 13, 202610-Q0001493152-26-022719
May 13, 2026SCHEDULE 13G/A0001213900-26-055876
Apr 22, 2026SCHEDULE 13G/A0000921895-26-001059
Apr 17, 2026DEFA14A0001493152-26-017911
Apr 17, 2026ARS0001493152-26-017912